Claritev financials
$21.17−2.17%
Close Sep 30, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $965.4M |
| Gross profit | $712.0M |
| Gross margin | 73.8% |
| Operating income | $45.1M |
| Net income | -$284.3M |
| Net margin | −29.4% |
| Diluted EPS | $-17.30 |
| EBITDA | $490.5M |
| Operating cash flow | $117.3M |
| Free cash flow | -$12.3M |
| Diluted shares | 16.4M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $16.8M |
| Short-term investments | $0.00 |
| Total debt | $4.70B |
| Total assets | $4.89B |
| Total liabilities | $5.06B |
| Shareholders' equity | -$167.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology